Office of Diversity and Inclusion
238%
Increase in Minority Graduate Students
(2016)
742
Faculty Members are Female
23%
Of Incoming Class Members are International Students
105
Faculty Members are from Minority Groups
Augustine M.K. Choi, MD
  • Stephen and Suzanne Weiss Dean Weill Cornell Medicine
  • Provost for Medical Affairs of Cornell University
"Diversity continues to be a major priority at Weill Cornell Medicine because we recognize that patient care, biomedical discovery, and learning are enriched by the contributions of people with different perspectives, skills, and life experiences. "
Hannah Valantine, MD, MRCP, FACC NIH Chief Officer for Scientific Workforce Diversity to Keynote Diversity Week

Weill Cornell Medicine’s inaugural DiversityWeek will take place April 23-27, 2018. Hosted by the Office of Diversity and Inclusion, it will include a series of events to celebrate and foster greater diversity among our community. Dr. Hannah Valantine, will deliver a keynote address on April 23rd, 2018. 

Dr. Hannah Valantine is the first NIH Chief Officer for Scientific Workforce Diversity, and a Senior Investigator in the Intramural Research Program at the National Heart, Lung, and Blood Institute. Prior to starting this position in April 2014, Dr. Valantine was Professor of Cardiovascular Medicine and the Senior Associate Dean for Diversity and Leadership at Stanford, a leadership position she held since November 2004. She is nationally recognized for her transformative approaches to diversity and is a recipient of the NIH Director’s Pathfinder Award for Diversity in the Scientific Workforce. She is currently leading NIH efforts to promote diversity through innovation across the NIH-funded biomedical workforce through a range of evidence-based approaches. Dr. Valantine maintains an active clinical research program that continues to have high impact on patient care. Current research extends her previous finding that an organ transplant is essentially a genome transplant, and that monitoring the level of donor DNA in a recipient’s blood as a marker of organ damage will detect early stages of rejection. She is currently overseeing a multi-site consortium of mid-Atlantic transplant centers to validate these findings clinically toward the development of a non-invasive tool for detecting early signs of organ rejection.

Other events, including diversity grand rounds, are being planned. If you have suggestions for activities, please feel free to contact Associate Deans for Diversity, Dr. Rache Simmons (rms2002@med.cornell.edu) and Dr. Linnie Golightly (lgolight@med.cornell.edu). We are looking forward to an engaging week that will bring together all members of our diverse and multitalented community.

 

Current Students

Weill Cornell Medicine offers a myriad of educational pathways to its diverse student body. Discover and apply to our vast array of medical, residency and graduate programs available now.

"The essence of Weill Cornell Medicine is community "
Raul Martinez-McFaline
Raul Martinez-McFaline
Tri-Institutional M.D./Ph.D. Student, WCM Student Overseer